SLC26A9 polymorphisms were linked to an increased risk of developing meconium ileus and pancreatic disease in people with CF [20,21,22], and higher expression of SLC26A9 correlates to a delayed manifestation of CF-related diabetes [23]. Here, SLC26A9 is linked to pancreas disorder.